-
1
-
-
0002160537
-
Eenvoudig dieet bij het syndroom van ee-erter
-
Dickie WK. Eenvoudig dieet bij het syndroom van ee-erter. Ned Tijdschr Geneeskd. 1941;85:1715.
-
(1941)
Ned Tijdschr Geneeskd
, vol.85
, pp. 1715
-
-
Dickie, W.K.1
-
3
-
-
84871629803
-
Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: A pilot randomized controlled trial
-
(Epub ahead of print). doi: 10.1007/s10620-012-2294-1
-
Shalimar, Das P, Sreenivas V, Datta Gupta S, Panda SK, Makharia GK. Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial. Dig Dis Sci. 2012. (Epub ahead of print). doi: 10.1007/s10620-012-2294-1.
-
(2012)
Dig Dis Sci.
-
-
Shalimar Das, P.1
Sreenivas, V.2
Datta Gupta, S.3
Panda, S.K.4
Makharia, G.K.5
-
4
-
-
0026423260
-
Celiac sprue
-
1944472 10.1056/NEJM199112123252406 1:STN:280:DyaK38%2FkvFKhsQ%3D%3D
-
Trier JS. Celiac sprue. N Engl J Med. 1991;325:1709-1719.
-
(1991)
N Engl J Med
, vol.325
, pp. 1709-1719
-
-
Trier, J.S.1
-
6
-
-
0034661814
-
Refractory sprue, coeliac disease, and enteropathy-associated t-cell lymphoma. French Coeliac Disease Study Group
-
10963198 10.1016/S0140-6736(00)02481-8 1:STN:280:DC%2BD3cvjtVemtw%3D%3D
-
Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated t-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356:203-208.
-
(2000)
Lancet
, vol.356
, pp. 203-208
-
-
Cellier, C.1
Delabesse, E.2
Helmer, C.3
Patey, N.4
Matuchansky, C.5
Jabri, B.6
MacIntyre, E.7
Cerf-Bensussan, N.8
Brousse, N.9
-
7
-
-
77953683769
-
Celiac crisis is a rare but serious complication of celiac disease in adults
-
20417725 10.1016/j.cgh.2010.04.009
-
Jamma S, Rubio-Tapia A, Kelly CP, et al. Celiac crisis is a rare but serious complication of celiac disease in adults. Clin Gastroenterol Hepatol. 2010;8:587-590.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 587-590
-
-
Jamma, S.1
Rubio-Tapia, A.2
Kelly, C.P.3
Murray, J.4
Najarian, R.5
Sheth, S.6
Schuppan, D.7
Dennis, M.8
Leffler, D.A.9
-
8
-
-
0019481215
-
The effect of the topical steroid clobetasone butyrate on coeliac mucosa maintained in organ culture
-
6788633 10.1159/000198584 1:CAS:528:DyaL3MXlsVCgsLc%3D
-
Bramble MG, Watson AJ, Record CO. The effect of the topical steroid clobetasone butyrate on coeliac mucosa maintained in organ culture. Digestion. 1981;21:316-324.
-
(1981)
Digestion
, vol.21
, pp. 316-324
-
-
Bramble, M.G.1
Watson, A.J.2
Record, C.O.3
-
9
-
-
0019777762
-
Clinical, biochemical and morphological responses of patients with villous atrophy to oral betamethasone valerate and clobetasone butyrate
-
7037504 10.1159/000198671 1:STN:280:DyaL387jvFyjsQ%3D%3D
-
Bramble MG, Watson AJ, Scott J, Peters TJ, Record CO. Clinical, biochemical and morphological responses of patients with villous atrophy to oral betamethasone valerate and clobetasone butyrate. Digestion. 1981;22:281-288.
-
(1981)
Digestion
, vol.22
, pp. 281-288
-
-
Bramble, M.G.1
Watson, A.J.2
Scott, J.3
Peters, T.J.4
Record, C.O.5
-
10
-
-
0026021383
-
A pilot study of fluticasone propionate in untreated coeliac disease
-
1901562 10.1136/gut.32.3.260 1:STN:280:DyaK3M7pt1Kmug%3D%3D
-
Mitchison HC, al Mardini H, Gillespie S, Laker M, Zaitoun A, Record CO. A pilot study of fluticasone propionate in untreated coeliac disease. Gut. 1991;32:260-265.
-
(1991)
Gut
, vol.32
, pp. 260-265
-
-
Mitchison, H.C.1
Al Mardini, H.2
Gillespie, S.3
Laker, M.4
Zaitoun, A.5
Record, C.O.6
-
11
-
-
0028071632
-
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group
-
8078529 10.1056/NEJM199409293311303 1:STN:280:DyaK2czlvFGntg%3D%3D
-
Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med. 1994;331:836-841.
-
(1994)
N Engl J Med
, vol.331
, pp. 836-841
-
-
Greenberg, G.R.1
Feagan, B.G.2
Martin, F.3
Sutherland, L.R.4
Thomson, A.B.5
Williams, C.N.6
Nilsson, L.G.7
Persson, T.8
-
12
-
-
0036928030
-
Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules
-
12468958 10.1097/00042737-200212000-00012
-
Edsbacker S, Larsson P, Wollmer P. Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules. Eur J Gastroenterol Hepatol. 2002;14:1357-1362.
-
(2002)
Eur J Gastroenterol Hepatol
, vol.14
, pp. 1357-1362
-
-
Edsbacker, S.1
Larsson, P.2
Wollmer, P.3
-
13
-
-
6044261115
-
Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease
-
15355126 10.2165/00003088-200443120-00003
-
Edsbacker S, Andersson T. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin Pharmacokinet. 2004;43:803-821.
-
(2004)
Clin Pharmacokinet
, vol.43
, pp. 803-821
-
-
Edsbacker, S.1
Andersson, T.2
-
14
-
-
33744462363
-
Therapy with budesonide in patients with refractory sprue
-
16612091 10.1159/000092639 1:CAS:528:DC%2BD28XjvFSmtrk%3D
-
Daum S, Ipczynski R, Heine B, Schulzke JD, Zeitz M, Ullrich R. Therapy with budesonide in patients with refractory sprue. Digestion. 2006;73:60-68.
-
(2006)
Digestion
, vol.73
, pp. 60-68
-
-
Daum, S.1
Ipczynski, R.2
Heine, B.3
Schulzke, J.D.4
Zeitz, M.5
Ullrich, R.6
-
15
-
-
34848889667
-
Budesonide in the treatment of refractory celiac disease
-
Brar P, Lee S, Lewis S, Egbuna I, Bhagat G, Green PH. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol. 2007;102:2265-2269.
-
(2007)
Am J Gastroenterol.
, vol.102
, pp. 2265-2269
-
-
Brar, P.1
Lee, S.2
Lewis, S.3
Egbuna, I.4
Bhagat, G.5
Green, P.H.6
-
16
-
-
72149097662
-
Efficacy of budesonide therapy in the early phase of treatment of adult celiac disease patients with malabsorption: An in vivo/in vitro pilot study
-
19473192 10.1111/j.1440-1681.2009.05211.x 1:CAS:528:DC%2BD1MXhsF2gs7%2FO
-
Ciacci C, Maiuri L, Russo I, et al. Efficacy of budesonide therapy in the early phase of treatment of adult celiac disease patients with malabsorption: an in vivo/in vitro pilot study. Clin Exp Pharmacol Physiol. 2009;36:1170-1176.
-
(2009)
Clin Exp Pharmacol Physiol
, vol.36
, pp. 1170-1176
-
-
Ciacci, C.1
Maiuri, L.2
Russo, I.3
Tortora, R.4
Bucci, C.5
Cappello, C.6
Santonicola, A.7
Luciani, A.8
Passananti, V.9
Iovino, P.10
-
17
-
-
0030463221
-
Increased small intestinal apoptosis in celiac disease
-
9038662 10.1136/gut.39.6.811 1:STN:280:DyaK2s7ptVOjsA%3D%3D
-
Moss SF, Attia L, Scholes JV, Walters JR, Holt PR. Increased small intestinal apoptosis in celiac disease. Gut. 1996;39:811-817.
-
(1996)
Gut
, vol.39
, pp. 811-817
-
-
Moss, S.F.1
Attia, L.2
Scholes, J.V.3
Walters, J.R.4
Holt, P.R.5
-
18
-
-
0034869813
-
Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in celiac disease
-
11511560 10.1136/gut.49.3.380
-
Di Sabatino A, Ciccocioppo R, D'Alo S, et al. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in celiac disease. Gut. 2001;49:380-386.
-
(2001)
Gut
, vol.49
, pp. 380-386
-
-
Di Sabatino, A.1
Ciccocioppo, R.2
D'Alo, S.3
Parroni, R.4
Millimaggi, D.5
Cifone, M.G.6
Corazza, G.R.7
-
20
-
-
21644446918
-
The international face of celiac disease
-
15570999 10.1016/j.dld.2004.07.003 1:STN:280:DC%2BD2crpslGgsg%3D%3D
-
Sharaf RN, Verna EC, Green PH. The international face of celiac disease. Dig Liver Dis. 2004;36:712-713.
-
(2004)
Dig Liver Dis
, vol.36
, pp. 712-713
-
-
Sharaf, R.N.1
Verna, E.C.2
Green, P.H.3
|